Liver Cancer Profile Differs in Black Patients With Hep C
Black patients have better liver function at the time of hepatocellular carcinoma diagnosis.
Hepatitis
Direct-Acting Antiviral Therapy Reduces Extrahepatic Manifestations of HCV
Studies have demonstrated an association between direct-acting antiviral therapy and a reduction in both the incidence and severity of extrahepatic manifestations of HCV.
HBV Infection Not Linked to Liver Injury, Mortality in COVID-19
Patients with current or past HBV infection are not at greater risk for liver injury or mortality during COVID-19 infection.
Predictors of Relapse in Patients With Chronic Hepatitis B Who Discontinue Nucleos(t)ide Analogue Therapy
Researchers analyzed data from patients with chronic hepatitis B to identify predictors of relapse in those who discontinued NAs and determined if existing rules for stopping NA therapy can be improved.
New Algorithm Predicts Advanced Liver Disease
The CIRRhosis Using Standard tests algorithm could use results of routine blood tests to identify patients at high risk for advanced liver disease
Updates to the 2021 Adult Immunization Schedule
The ACIP emphasizes the importance of routine vaccinations during the pandemic to prevent diseases.
Bacterial Infections, Severe Alcoholic Hepatitis Affect Course of Decompensated Cirrhosis
An international team of investigators conducted a multicenter, prospective, observational study to identify factors contributing to acute decompensation of cirrhosis.
American College of Physicians Updates Best Practice Advice for Chronic HCV
Based on guidelines issued by the World Health Organizations in 2018, the American College of Physicians has issued best practice advice that simplifies and improves treatment of chronic hepatitis C virus.
SHEA Updates Guidance for Health Care Staff With Hepatitis, HIV
In a Society for Healthcare Epidemiology of America white paper, updated recommendations are presented for health care personnel living with hepatitis and HIV.
Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment
Administration of simeprevir is more problematic with ART; sofosbuvir has fewest interactions with ART.
- Loading...
Loading...
Next post in HIV/AIDS Information Center
Loading... 
Loading...